Molina Healthcare vs Oscar Health
MOH and OSCR side by side, both in accident and health insurance and medical. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MOH and OSCR compare
Molina Healthcare and Oscar Health are about the same size, with market caps of $10.7B and $9.4B.
Oscar Health grew revenue faster over the last twelve months (42.8% versus 2.6% for Molina Healthcare).
Oscar Health keeps more of each dollar of sales as profit, with a net margin of 3.6% compared with −0.02% at Molina Healthcare.
Oscar Health scores higher on the StockData Score (11 against 5 for Molina Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MOH | OSCR |
|---|---|---|
| Size and price | ||
| Market cap | $10.7B | $9.4B |
| Share price | $204.78 | $30.37 |
| Change, 1 year | 27.8% | 60.6% |
| Change, 5 years | −32.7% | 78.6% |
| Beta (5Y) | 0.25 | 1.65 |
| Employees | 19K | 2,305 |
| StockData Score | ||
| Total score | 5 | 11 (better) |
| Valuation score | 1 | 1 |
| Growth score | 2 | 2 |
| Performance score | 0 | 4 (better) |
| Health score | 2 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 21.7× |
| P/S | 0.2× (better) | 0.6× |
| P/B | 2.6× (better) | 4.6× |
| EV/EBITDA | 14.9× | 1.9× (better) |
| P/FCF | 39.4× | 2.1× (better) |
| FCF yield | 2.5% | 46.7% (better) |
| Fair value | – | $23.67 |
| Margin of safety | – | −28.3% |
| Growth | ||
| Revenue growth (TTM) | 2.6% | 42.8% (better) |
| Revenue growth, 5Y average | 18.5% | 90.8% (better) |
| Net income growth (TTM) | −101% | – |
| EPS growth (TTM) | −101% | – |
| EPS growth, 5Y average | −4.5% | – |
| Profitability | ||
| Gross margin | 12.6% | – |
| Operating margin | 0.46% | 4.1% (better) |
| Net margin | −0.02% | 3.6% (better) |
| FCF margin | 0.61% | 28.6% (better) |
| Return on equity | −0.16% | 34.3% (better) |
| Financial health | ||
| Debt / equity | 0.90 | 0.21 (better) |
| Net debt / EBITDA | −13.87 | −12.35 |
| Interest coverage | 1.0× | 39.7× (better) |
| Current ratio | 1.68 (better) | 1.08 |
| Altman Z-score | 4.08 (better) | 1.95 |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | 4.7% | – |
| Shareholder yield | 4.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 108% | 64.7% |
| Held by insiders | 1.5% | 20.9% |
| Insider net buying, 12 months | −$3.5M (better) | −$138M |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 5.6% | 6.7% |
Go deeper
- MOH stock overview
- MOH income statement
- MOH valuation and score
- OSCR stock overview
- OSCR income statement
- OSCR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.